Cognition Therapeutics Inc - CGTX STOCK NEWS

IMPACT

SENTIMENT

11/16/2023 07:30 AM

CGTX : Nasdaq

Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip Scheltens

IMPACT

SENTIMENT

11/15/2023 07:30 AM

CGTX : Nasdaq

Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s Diseases

IMPACT

SENTIMENT

11/07/2023 07:30 AM

CGTX : Nasdaq

Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease

IMPACT

SENTIMENT

11/02/2023 07:30 AM

CGTX : Nasdaq

Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

IMPACT

SENTIMENT

10/27/2023 07:30 AM

CGTX : Nasdaq

Cognition Therapeutics and Collaborators at Yale and ACTC Announce Oral Late-breaking Presentation on the START Study in Early Alzheimer’s Disease at CTAD

IMPACT

SENTIMENT

10/24/2023 04:30 PM

CGTX : Nasdaq

Cognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at CTAD

IMPACT

SENTIMENT

09/07/2023 07:45 AM

CGTX : Nasdaq

Cognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the Retina in Dry AMD

IMPACT

SENTIMENT

08/30/2023 08:00 AM

CGTX : Nasdaq

Cognition Therapeutics Announces Participation in Upcoming September Conferences

IMPACT

SENTIMENT

08/08/2023 07:00 AM

CGTX : Nasdaq

Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update

IMPACT

SENTIMENT

08/02/2023 07:30 AM

CGTX : Nasdaq

Cognition Therapeutics to Report Second Quarter 2023 Results in Conference Call on Tuesday, August 8, 2023

Cognition Therapeutics Inc

Nasdaq:CGTX

CGTX Rankings

#6078 Ranked by Market Cap

N/A Ranked by Dividends

CGTX Stock Data

Industry Biological Product (except Diagnostic) Manufacturing

Sector Manufacturing

Website Link

Country United States

City Purchase

About CGTX

cognition therapeutics inc. is a drug discovery and development company located in pittsburgh, pennsylvania. founded in 2007, the company uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system.